| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |